ALLO-647 (Anti-CD52 mAb): Selective Lymphodepletion May Delay Graft Rejection
ALLO-647 intended to enable expansion and persistence of allogeneic CAR T product candidates. Host T cell recovery is delayed by addition of anti-CD52.
ALLO-647 intended to enable expansion and persistence of allogeneic CAR T product candidates. Host T cell recovery is delayed by addition of anti-CD52.